AbbVie Inc (NYSE: ABBV)

DRUGS - Drug Manufacturers - Major
Sector: Health Care

Stock price data as of 02/21/2025

Closing price: 202.08

Support price level:	$182.23
Resistance price level:	N/A
Relative strength index (14-day RSI)	86.4
Beta	0.09

ABBV is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
ABBV is one of this month's top performers with a return of 18.4 percent, beating 90 percent of stocks in the S&P-100.
Up 4.5 percent, ABBV is one of this week's biggest gainers.
The price of this low-beta stock is expected to increase by 0.09% for every 1% increase in the S&P-500.
Volatility is forecast to fall over the next month.
With RSI > 70, ABBV is overbought. Odds slightly favor a short-term price reversal.
Price broke above prior resistance level - a short-term bullish signal.

Low	High	Price as % of Range
$154.79	$203.87	96.8%

200 day	50 day	20 day	10 day
$180.98	$180.71	$188.51	$194.87

(Annualized standard deviation)

Historical (5 year)	Last month	Current estimate	Next month forecast
25.0%	25.5%	20.4%	23.3%

There is an estimated 5% probability that the stock price of AbbVie Inc will fall by more than: